6472 — BORA PHARMACEUTICALS Share News
0.000.00%
Last trade - 00:00- TWD50.96bn
- TWD66.70bn
- TWD19.01bn
Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine (updated)
Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine
Brief: Bora Pharmaceuticals & GSK Sign $250M Five Year Global Manufacturing Contract
Brief: Bora Pharmaceuticals Says Jan-Sept Net Profit T$2.65 Bln
Brief: Bora Pharmaceuticals Plans To Sell Up To 12.44 Million Shares On US Makret
Brief: Bora Pharmaceuticals Says Jan-Jun Net Profit T$2.02 Bln
Brief: Bora Pharmaceuticals Says Q1 Net Profit T$1.4 Bln
Brief: Bora Pharmaceuticals Says 2024 Full-Year Net Profit T$3.94 Bln
Brief: Tanvex Biopharma Announces Merger Plan With Unit Of Bora Pharmaceuticals
Brief: Emergent BioSolutions Announces Sale Of Baltimore-Camden Manufacturing Site To Bora Pharmaceuticals
Brief: Bora Pharmaceuticals Says To Sell Bond For Up To $200 Mln Overseas
Brief: Bora Pharmaceuticals Says Completes Management Takeover Of Upsher-Smith Laboratories After Merger
Brief: Bora Pharmaceuticals Says 2023 Net Profit At T$3.03 Bln
To Transfer All Of Its Stake In Sawai America Holdings To Sumitomo Corporation Of Americas, Bora Pharmaceutical Holdings
Brief: Bora Pharmaceuticals Buys Upsher-Smith Laboratories For $210 Mln
Brief: Impax Announces Sale Of Taiwan Manufacturing Facility